105 related articles for article (PubMed ID: 34958129)
1. Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series.
Masuka JT; Mchunu N; Mkhize Z; Thandar Y; Mosam A
Australas J Dermatol; 2022 Feb; 63(1):e13-e20. PubMed ID: 34958129
[TBL] [Abstract][Full Text] [Related]
2. Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis.
Tan B; Chen L; Yan S; Pan H; Zhang J; Wei H
Sci Rep; 2024 Jul; 14(1):15167. PubMed ID: 38956425
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
Khanassov V; Hu J; Reeves D; van Marwijk H
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
[TBL] [Abstract][Full Text] [Related]
4. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials.
Wang L; Tobe J; Au E; Tran C; Jomy J; Oparin Y; Couban RJ; Paul J
Br J Anaesth; 2022 Jan; 128(1):118-134. PubMed ID: 34756632
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
Azizi M; Khani S; Kamali M; Elyasi F
Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
[TBL] [Abstract][Full Text] [Related]
7. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
Bailey AL; Makela EH; Asberg K
J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
[TBL] [Abstract][Full Text] [Related]
8. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
Meng Y; Yuen J
J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
[No Abstract] [Full Text] [Related]
9. SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
Hosenbocus S; Chahal R
J Can Acad Child Adolesc Psychiatry; 2011 Feb; 20(1):60-7. PubMed ID: 21286371
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
[TBL] [Abstract][Full Text] [Related]
11. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
Rozner L; Aisenberg Romano G; Klieger C; Bloch M
Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
[TBL] [Abstract][Full Text] [Related]
12. Association between selective serotonin and serotonin-noradrenaline reuptake inhibitor therapy and hematuria.
Sarier M; Demir M; Emek M; Özgen A; Turgut H; Özdemir C
Nord J Psychiatry; 2023 Jan; 77(1):31-35. PubMed ID: 35243962
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.
Alfares I; Javaid MS; Chen Z; Anderson A; Antonic-Baker A; Kwan P
CNS Drugs; 2021 Feb; 35(2):161-176. PubMed ID: 33580477
[TBL] [Abstract][Full Text] [Related]
14. Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm.
Kelly JM; Rubenfeld GD; Masson N; Min A; Adhikari NKJ
Crit Care Med; 2017 Jun; 45(6):e607-e616. PubMed ID: 28338497
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Handley AP; Williams M
J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
[TBL] [Abstract][Full Text] [Related]
16. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants.
Ahmadimanesh M; Balarastaghi S; Rashedinia M; Yazdian-Robati R
Psychopharmacology (Berl); 2020 Jul; 237(7):1909-1915. PubMed ID: 32529266
[TBL] [Abstract][Full Text] [Related]
17. A systematic approach for developing a corpus of patient reported adverse drug events: A case study for SSRI and SNRI medications.
Zolnoori M; Fung KW; Patrick TB; Fontelo P; Kharrazi H; Faiola A; Wu YSS; Eldredge CE; Luo J; Conway M; Zhu J; Park SK; Xu K; Moayyed H; Goudarzvand S
J Biomed Inform; 2019 Feb; 90():103091. PubMed ID: 30611893
[TBL] [Abstract][Full Text] [Related]
18. Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders.
Colombo A; Giordano F; Giorgetti F; Di Bernardo I; Bosi MF; Varinelli A; Cafaro R; Pileri P; Cetin I; Clementi E; Viganò CA; Dell'Osso B
Hum Psychopharmacol; 2021 May; 36(3):e2772. PubMed ID: 33253437
[TBL] [Abstract][Full Text] [Related]
19. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database.
Benevent J; Araujo M; Karki S; Delarue-Hurault C; Waser J; Lacroix I; Tebeka S; Damase-Michel C
J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37437238
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
